Correlation Between Alkame Holdings and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alkame Holdings and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alkame Holdings and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alkame Holdings and Aerovate Therapeutics, you can compare the effects of market volatilities on Alkame Holdings and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alkame Holdings with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alkame Holdings and Aerovate Therapeutics.
Diversification Opportunities for Alkame Holdings and Aerovate Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Alkame and Aerovate is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Alkame Holdings and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Alkame Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alkame Holdings are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Alkame Holdings i.e., Alkame Holdings and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Alkame Holdings and Aerovate Therapeutics
Given the investment horizon of 90 days Alkame Holdings is expected to under-perform the Aerovate Therapeutics. In addition to that, Alkame Holdings is 10.62 times more volatile than Aerovate Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.08 per unit of volatility. If you would invest 266.00 in Aerovate Therapeutics on September 13, 2024 and sell it today you would lose (10.00) from holding Aerovate Therapeutics or give up 3.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Alkame Holdings vs. Aerovate Therapeutics
Performance |
| Timeline |
| Alkame Holdings |
| Aerovate Therapeutics |
Alkame Holdings and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alkame Holdings and Aerovate Therapeutics
The main advantage of trading using opposite Alkame Holdings and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alkame Holdings position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.| Alkame Holdings vs. V Group | Alkame Holdings vs. Fbec Worldwide | Alkame Holdings vs. Hiru Corporation | Alkame Holdings vs. Bank of America |
| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |